Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids. - Suppr | 超能文献

Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids.

作者信息

Gurumurthy P, Nair N G, Sarma G R

出版信息

Indian J Med Res. 1980 Jan;71:129-34.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids.

Indian J Med Res. 1980 Jan;71:129-34.

2

[Microdetermination of pyrazinamide and its metabolites (pyrazinoic acid, 5-hydroxypyrazinoic acid, 5-hydroxypyrazinamide and pyrazinuric acid) in plasma and urine with liquid chromatography].[用液相色谱法微量测定血浆和尿液中的吡嗪酰胺及其代谢产物（吡嗪酸、5-羟基吡嗪酸、5-羟基吡嗪酰胺和吡嗪尿酸）]

J Chromatogr. 1987 Nov 27;422:217-25.

3

[Polarographic quantification of pyrazinamide and benemycin in biological fluids].[生物体液中吡嗪酰胺和苯那霉素的极谱定量分析]

Probl Tuberk. 1977 Jan(1):71-5.

4

[Simultaneous microdetermination of pyrazinamide and pyrazinoic acid by liquid chromatography].[液相色谱法同时微量测定吡嗪酰胺和吡嗪酸]

Ann Biol Clin (Paris). 1987;45(3):297-9.

5

Mass fragmentographic determination of pyrazinamide and its metabolites in serum and urine.血清和尿液中吡嗪酰胺及其代谢物的质量碎片分析法测定

J Chromatogr. 1978 Jan 11;147:337-47. doi: 10.1016/s0021-9673(00)85145-6.

6

Pyrazinamide and pyrazinoic acid pharmacokinetics in patients with chronic renal failure.慢性肾衰竭患者中吡嗪酰胺和吡嗪酸的药代动力学

Clin Nephrol. 1988 Oct;30(4):230-4.

7

HPLC assay of pyrazinoic acid in human plasma in the presence of pyrazinamide and other antituberculosis drugs using an automatic sampler.使用自动进样器在吡嗪酰胺和其他抗结核药物存在的情况下对人血浆中吡嗪酸进行高效液相色谱测定。

Farmaco Prat. 1982 Jul;37(7):226-34.

8

Rapid liquid chromatographic method for the estimation of isoniazid and pyrazinamide in plasma and urine.用于测定血浆和尿液中异烟肼和吡嗪酰胺的快速液相色谱法。

J Chromatogr. 1990 Nov 16;532(2):418-23. doi: 10.1016/s0378-4347(00)83793-7.

9

Study of the metabolism of pyrazinamide using a high-performance liquid chromatographic analysis of urine samples.采用高效液相色谱法分析尿液样本对吡嗪酰胺代谢情况的研究。

Anal Biochem. 1987 Feb 1;160(2):346-9. doi: 10.1016/0003-2697(87)90058-3.

10

Iron enhances the antituberculous activity of pyrazinamide.铁可增强吡嗪酰胺的抗结核活性。

J Antimicrob Chemother. 2004 Feb;53(2):192-6. doi: 10.1093/jac/dkh042. Epub 2004 Jan 16.

引用本文的文献

1

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.晚期人类免疫缺陷病毒病患者中利福平及其他抗结核药物的生物利用度降低。

Antimicrob Agents Chemother. 2004 Nov;48(11):4473-5. doi: 10.1128/AAC.48.11.4473-4475.2004.

2

Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.口服含异烟肼、利福平及吡嗪酰胺的聚（丙交酯-乙交酯）微粒对实验性结核病的化疗潜力

Antimicrob Agents Chemother. 2003 Sep;47(9):3005-7. doi: 10.1128/AAC.47.9.3005-3007.2003.

3

The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.吡嗪酰胺的血/脑脊液分配：一项在结核性脑膜炎治疗过程中的研究。

J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):81-2. doi: 10.1136/jnnp.53.1.81.